PL1988090T3 - Pochodne kwasu imidazolo-5-karboksylowego, sposoby przygotowania i ich zastosowanie - Google Patents

Pochodne kwasu imidazolo-5-karboksylowego, sposoby przygotowania i ich zastosowanie

Info

Publication number
PL1988090T3
PL1988090T3 PL06775249T PL06775249T PL1988090T3 PL 1988090 T3 PL1988090 T3 PL 1988090T3 PL 06775249 T PL06775249 T PL 06775249T PL 06775249 T PL06775249 T PL 06775249T PL 1988090 T3 PL1988090 T3 PL 1988090T3
Authority
PL
Poland
Prior art keywords
therrof
imidazol
carboxylic acid
acid derivatives
preparation methods
Prior art date
Application number
PL06775249T
Other languages
English (en)
Inventor
Jianhui Guo
Dong An
Original Assignee
Salubris Asset Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salubris Asset Man Co Ltd filed Critical Salubris Asset Man Co Ltd
Publication of PL1988090T3 publication Critical patent/PL1988090T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
PL06775249T 2006-02-20 2006-07-31 Pochodne kwasu imidazolo-5-karboksylowego, sposoby przygotowania i ich zastosowanie PL1988090T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNA2006100239910A CN101024643A (zh) 2006-02-20 2006-02-20 咪唑-5-羧酸类衍生物、制备方法及其应用
PCT/CN2006/001914 WO2007095789A1 (fr) 2006-02-20 2006-07-31 Dérivés d'acide imidazol-5-carboxylique, leurs procédés de préparation et leur utilisation
EP06775249.3A EP1988090B1 (en) 2006-02-20 2006-07-31 Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof

Publications (1)

Publication Number Publication Date
PL1988090T3 true PL1988090T3 (pl) 2013-10-31

Family

ID=38436915

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06775249T PL1988090T3 (pl) 2006-02-20 2006-07-31 Pochodne kwasu imidazolo-5-karboksylowego, sposoby przygotowania i ich zastosowanie

Country Status (12)

Country Link
US (2) USRE44873E1 (pl)
EP (1) EP1988090B1 (pl)
JP (1) JP5250760B2 (pl)
KR (1) KR101179110B1 (pl)
CN (2) CN101024643A (pl)
AU (1) AU2006338796B2 (pl)
CA (1) CA2643005C (pl)
DK (1) DK1988090T3 (pl)
ES (1) ES2424154T3 (pl)
PL (1) PL1988090T3 (pl)
PT (1) PT1988090E (pl)
WO (1) WO2007095789A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101024643A (zh) 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑-5-羧酸类衍生物、制备方法及其应用
CA2671816C (en) * 2006-12-06 2012-06-05 Shanghai Allist Pharmaceutical., Inc. Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same
CN101214242A (zh) * 2007-01-05 2008-07-09 上海艾力斯医药科技有限公司 新的药用组合物
CN101317842A (zh) 2007-06-07 2008-12-10 上海艾力斯医药科技有限公司 一种咪唑-5-羧酸衍生物的治疗用途
CN101407511B (zh) * 2007-10-11 2013-01-09 上海艾力斯生物医药有限公司 一种结晶型的咪唑-5-羧酸衍生物
WO2009140111A1 (en) * 2008-05-15 2009-11-19 Merck & Co., Inc. Angiotensin ii receptor antagonists
CN101596189A (zh) * 2008-06-05 2009-12-09 上海艾力斯生物医药有限公司 含有咪唑-5-羧酸类衍生物的药用组合物
EP2365966A4 (en) * 2008-12-12 2012-05-09 Pharmacostech Co Ltd PROCESS FOR REMOVING THE TRIPHENYLMETHANE GRIP
KR101213467B1 (ko) * 2010-04-30 2012-12-20 진양제약주식회사 로자탄 대사체 이엑스피-3174 이수화물의 신규한 제조 방법
CN103012377A (zh) * 2011-09-27 2013-04-03 江苏艾力斯生物医药有限公司 一种咪唑-5-羧酸酯的重结晶方法
CN102558064B (zh) * 2012-01-29 2014-04-16 安润医药科技(苏州)有限公司 抗高血压化合物及其制备方法和应用,以及其在药学上可接受的盐
CN109320501B (zh) * 2013-11-01 2021-06-01 深圳信立泰药业股份有限公司 阿利沙坦酯无定形及其制备方法及含所述无定形的药物组合物
CN103965171A (zh) * 2014-04-30 2014-08-06 上海艾力斯医药科技有限公司 一种阿利沙坦酯的制备方法
CN106188012B (zh) * 2014-06-20 2018-11-30 深圳信立泰药业股份有限公司 一种阿利沙坦酯结晶及其制备方法及含有该结晶的药物组合物
CN105218527B (zh) * 2015-10-10 2018-04-24 江苏宝众宝达药业有限公司 一种exp-3174的制备方法
MX2018008531A (es) 2016-01-20 2019-05-15 Shenzhen Salubris Pharm Co Ltd Compuestos del metabolito del antagonista del receptor de angiotensina ii y del inhibidor de nep, y metodos de preparacion de los mismos.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5138069A (en) 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5196444A (en) 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5616599A (en) 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
AT398202B (de) * 1991-10-04 1994-10-25 Chem Pharm Forsch Gmbh Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
ES2155827T3 (es) * 1992-06-02 2001-06-01 Sankyo Co 4-carboxiimidazoles como antagonistas de la angiotensina ii y su uso terapeutico.
JPH083162A (ja) * 1994-04-19 1996-01-09 Tanabe Seiyaku Co Ltd イミダゾピリジン誘導体及びその製法
RU2166330C2 (ru) * 1995-06-07 2001-05-10 Джи. Ди. Сирл Энд Ко. Комбинация, содержащая антагонист рецептора ангиотензина ii и эпоксистероидный антагонист рецептора альдостерона
UA87983C2 (ru) 2003-07-31 2009-09-10 Никокс С.А. Производные блокиратора рецептора ангиотензина ii
AU2004270161A1 (en) * 2003-08-28 2005-03-17 Nicox S.A. Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
JP5051897B2 (ja) 2005-04-22 2012-10-17 第一三共株式会社 骨代謝性疾患の予防又は治療のための医薬
CN101024643A (zh) 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑-5-羧酸类衍生物、制备方法及其应用
CA2671816C (en) 2006-12-06 2012-06-05 Shanghai Allist Pharmaceutical., Inc. Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same
CN101214242A (zh) 2007-01-05 2008-07-09 上海艾力斯医药科技有限公司 新的药用组合物
CN101317842A (zh) 2007-06-07 2008-12-10 上海艾力斯医药科技有限公司 一种咪唑-5-羧酸衍生物的治疗用途
CN101407511B (zh) 2007-10-11 2013-01-09 上海艾力斯生物医药有限公司 一种结晶型的咪唑-5-羧酸衍生物

Also Published As

Publication number Publication date
EP1988090A1 (en) 2008-11-05
CA2643005A1 (en) 2007-08-30
AU2006338796A1 (en) 2007-08-30
CN101031562A (zh) 2007-09-05
JP5250760B2 (ja) 2013-07-31
KR101179110B1 (ko) 2012-09-07
CA2643005C (en) 2012-05-15
WO2007095789A1 (fr) 2007-08-30
DK1988090T3 (da) 2013-08-05
KR20080096707A (ko) 2008-10-31
US20090036505A1 (en) 2009-02-05
US7858651B2 (en) 2010-12-28
PT1988090E (pt) 2013-08-05
EP1988090A4 (en) 2010-06-30
JP2009527509A (ja) 2009-07-30
CN101024643A (zh) 2007-08-29
EP1988090B1 (en) 2013-05-01
ES2424154T3 (es) 2013-09-27
CN100506818C (zh) 2009-07-01
USRE44873E1 (en) 2014-04-29
AU2006338796B2 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
PL1988090T3 (pl) Pochodne kwasu imidazolo-5-karboksylowego, sposoby przygotowania i ich zastosowanie
EP1990337A4 (en) CHINAZOLINE DERIVATIVES, METHOD OF MANUFACTURE AND USES THEREOF
HK1121757A1 (en) Pyrroloazacyclic derivatives, preparing method and use thereof
ZA201005202B (en) Azabicyclic carboxamide derivatives,preparation thereof and theapeutic use thereof
EP2124550A4 (en) OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND THEIR USE
PL2046405T3 (pl) Biomateriały, ich wytwarzanie i zastosowanie
ZA200805939B (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
SI2069342T1 (sl) Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
HK1159108A1 (en) Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
ZA200901268B (en) Substituted imidazolone derivatives, preparation and uses
HK1117164A1 (en) Dicyclic azaalkane derivatives, preparing method and pharmaceutical use thereof
HK1151791A1 (en) Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
IL180682A0 (en) N-hydroxamide derivatives, their preparation and use
ZA201002307B (en) Quinazolinedione derivatives,preparation thereof and therapeutic uses thereof
EP2283005A4 (en) CISATRACURIUM DERIVATIVES, PREPARATION AND USES THEREOF
EP1961753A4 (en) DERIVATIVES OF PIRAZOLOPYRIMIDINONE, THEIR PREPARATION AND USE
IL192427A0 (en) Derivatives of sulindac, use thereof and preparation thereof
HUP0500921A2 (en) Tetrazole derivatives, process for their preparation and their use
IL193155A0 (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
IL201416A0 (en) Triazolopyridine carboxamide derivatives, preparation thereof and theraputic use thereof
EP2292234A4 (en) COMPOSITION CONTAINING QUINAZOLINE DERIVATIVES, PROCESS FOR PREPARING SAME AND APPLICATIONS THEREOF.
GB0719592D0 (en) Compound, use and method
IL193384A0 (en) Substituted prolinamides, their preparation and their use as pharmaceuticals
EP2048134A4 (en) MEPTAZINOL DERIVATIVES WITH TWO LIGANDS AND / OR THEIR SALTS, PROCESS FOR PREPARING THEM AND APPLICATIONS THEREOF
GB0607562D0 (en) Method, composition and use